Shu XM - Search Results

1

[Myositis disease activity tool in Chinese patients with polymyositis/dermatomyositis].

Shu XM, Ma L, Lu X, Xie Y, Wang GC. Shu XM, et al. Zhonghua Yi Xue Za Zhi. 2011 May 24;91(19):1328-30. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21756759 Chinese.

2

Rheumatoid-like deformities in Parkinson's disease with 1-year follow-up: case report and literature review.

Shu X, Wang G, Lu X, Xie Y. Shu X, et al. Rheumatol Int. 2010 Sep;30(11):1493-7. doi: 10.1007/s00296-009-1094-1. Epub 2009 Sep 2. Rheumatol Int. 2010. PMID: 19727735 Review.

3

Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China.

Shu XM, Lu X, Xie Y, Wang GC. Shu XM, et al. BMC Neurol. 2011 Nov 9;11:143. doi: 10.1186/1471-2377-11-143. BMC Neurol. 2011. PMID: 22070623 Free PMC article.

4

Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis.

Chen F, Wang D, Shu X, Nakashima R, Wang G. Chen F, et al. Rheumatol Int. 2012 Dec;32(12):3909-15. doi: 10.1007/s00296-011-2323-y. Epub 2011 Dec 25. Rheumatol Int. 2012. PMID: 22198664

5

Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.

Wang DX, Shu XM, Tian XL, Chen F, Zu N, Ma L, Wang GC. Wang DX, et al. Among authors: shu xm. Clin Rheumatol. 2012 May;31(5):801-6. doi: 10.1007/s10067-012-1940-5. Epub 2012 Jan 26. Clin Rheumatol. 2012. PMID: 22274797 Review.

6

[Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits/dermatomyosits].

Chen F, Shu XM, Wang DX, Wang GC, Lu X. Chen F, et al. Among authors: shu xm. Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Apr 18;44(2):204-8. Beijing Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22516988 Free article. Chinese.

7

[The levels and clinical significance of serum B cell activating factor in Chinese patients with polymyositis or dermatomyositis].

Peng QL, Xie Y, Zhang RF, Shu XM, Wang GC. Peng QL, et al. Among authors: shu xm. Zhonghua Nei Ke Za Zhi. 2012 Mar;51(3):210-3. Zhonghua Nei Ke Za Zhi. 2012. PMID: 22781895 Chinese.

8

Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis.

Wang DX, Lu X, Zu N, Lin B, Wang LY, Shu XM, Ma L, Wang GC. Wang DX, et al. Among authors: shu xm. Clin Rheumatol. 2012 Dec;31(12):1691-7. doi: 10.1007/s10067-012-2075-4. Epub 2012 Aug 30. Clin Rheumatol. 2012. PMID: 22933126

9

[Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].

Chen F, Shu XM, Wang DX, Xie Y, Wang GC. Chen F, et al. Among authors: shu xm. Zhonghua Yi Xue Za Zhi. 2012 Aug 21;92(31):2182-5. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23158422 Chinese.

10

Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.

Peng QL, Shu XM, Tian XL, Lu X, Wang GC. Peng QL, et al. Among authors: shu xm. Arthritis Res Ther. 2014 Jan 27;16(1):R26. doi: 10.1186/ar4454. Arthritis Res Ther. 2014. PMID: 24467773 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters